Dr Andy Muinonen-Martin
MBChB, MRCP UK (Dermatology), MRCP, PhD
I am a Consultant Dermatologist at Spire Leeds Hospital with expertise in the field of skin cancer, and in particular, the diagnosis and management of melanoma. At my clinic Spire Leeds clinic, I offer this expertise, along with a bespoke mole assessment and mapping service - seeing anyone who is worried about a single mole through to patients with hundreds of atypical moles and or a family history of melanoma. The detailed and thorough assessment is carried out in a calm and unrushed manner and will focus on you and your skin cancer risk factors. Through education, I empower my patients to confidently be able to monitor their skin and recognise melanoma early.
I also diagnose and manage sun damaged skin through to all other skin cancers, either medically or surgically and I have 15 years of skin surgical experience. I continue to practice general dermatology and consult on all types of skin problems ranging from acne, eczema and psoriasis through to all types of rare and challenging skin conditions.
I completed my undergraduate medical training at the University of Edinburgh in 2002, and later went on to specialise in dermatology in Glasgow. I was awarded a prestigious Wellcome Trust Research Training Fellowship to complete a PhD at the CRUK Beatson Institute of Cancer Research, with the results published in a world-leading journal as well as national and international newspapers and blogs. This research has helped to further develop our understanding of how melanoma cells communicate and spread.
Since finishing my training, I have worked as a Consultant Dermatologist in York, where I was Skin Cancer Lead for five years and pioneered teledermatology in the region, alongside specialist melanoma work in Leeds. In 2019, I transitioned to Leeds, to expand my work in the specialist mole (pigmented lesion) assessment and melanoma clinic where we manage the most complex and high-risk cases across Yorkshire. I developed and lead the injectable gene therapy (TVEC) service there, which is the first of its kind for any cancer group in the region.
In addition to my work with patients, I continue to carry out clinical and academic research, teach locally, nationally and internationally and have consulted on a BBC melanoma documentary.
I am currently chairing the development of national immunotherapy guidelines and helping to shape innovative virtual referral pathways for patients. I am in the process of opening and running an important trial investigating the ability of simple blood tests to detect microscopic recurrences of melanoma alongside standard practice and I am a member of the Trial Management Group for this potentially ground breaking international study. I am also keen to increase public awareness and understanding about skin cancer and continue to work with local news outlets, charities and schools to do this.
Some of the principal treatments carried out by Dr Andy Muinonen-Martin at Spire include:
COVID-19 testing or antibody tests are not available as a standalone service at Spire Leeds Hospital.
MBChB / University of Edinburgh / 2002
Bachelor of Medicine, Bachelor of Surgery
MRCP / Royal College of Physicians, Edinburgh / 2006
Member, Royal College of Physicians, Edinburgh
MRCP (Dermatology) / Royal College of Physicians, Edinburgh / 2013
Specialist Certificate in Dermatology, Glasgow
PhD / University of Glasgow / 2014
Doctor of Philosophy
British Association of Dermatologists
Royal College of Physicians of Edinburgh
National Chair of new cutaneous toxicity immunotherapy UK guidelines
Core member and rotating Chair of the regional/Leeds melanoma specialist multi-disciplinary team
Lead for the Regional TVEC (injectable gene therapy for metastatic melanoma) treatment at St James’s University Hospital, Leeds
Trial management group member and Principal Investigator at Leeds of forthcoming Cancer Research UK funded international melanoma circulating tumour cell DNA study
Co-creator of the Yorkshire Dermoscopy Course training: GPs, nurse specialists, dermatologists and plastic surgeons) nationally and internationally
Regional dermatology educational programme lead
Cancer Research UK Melanoma Detection study: Circulating Tumour DNA guidEd Therapy for Stage IIB/C mElanoma After surgiCal resection
A British Journal of Dermatology systematic review paper: Effectiveness of interventions to support the early detection of skin-cancer through skin self-examination: a systematic review and meta-analysis. Ersser SJ, Effah A, Dyson J, Kellar I, Thomas S, McNichol E, Caperon E, Hewitt C, Muinonen-Martin AJ. Br J Dermatol
Invited author on a British Medical Journal review paper on difficult to diagnose melanoma: Amelanotic melanoma. Muinonen-Martin AJ, O'Shea SJ, Newton-Bishop J. BMJ. 2018 Mar 15;360:k826.
Main melanoma PhD paper from Wellcome Trust funded Clinical Research Training Fellowship: Melanoma cells make LPA gradients that drive their chemotactic dispersal and invasion. A. J. Muinonen-Martin, Q. Zhang, W. Faller, O.Susanto, D. Veltman, G. Kalna, C. Lindsay, D. C. Bennett, O. J. Sansom, R. Herd, R. Jones, L. M. Machesky, M. J. O. Wakelam, D. A. Knecht, & R. H. Insall. PLoS Biol. 2014 Oct 14;12(10):e1001966.
Consultant Dermatologist, Leeds Teaching Hospitals Trust
Honorary Senior Lecturer, University of Leeds
Whilst I am passionate about my specialist and general dermatology work, at home, I am married to a wonderful wife and have two energetic free-spirited young children. My favourite past times include getting outside and fell running or cycling, and inside strumming the guitar, along with live music and dancing.
|Telephone||Insured patients 0113 218 5908/9, self-pay patients 0113 218 5967|
|Private secretary||Jade Ramsden|
|Private secretary telephone||07983 396174|
|Private secretary email@example.com|